Γ—

Oisin Biotechnologies

Organization Description

Oisin Biotechnologies are developing a plasmid-based approach to destroying senescent and cancer cells. This approach may allow for higher selectivity when compared to drug approaches and could reduce side effects too.

To do this, we need your support. Your charitable contribution tranforms into rejuvenation research, news, shows, and more. Will you help?

Team

Gary Hudson

Oisin Biotechnologies - Executive Chairman

Stephen Hilbert

Oisin Biotechnologies - CBO

Related Topics